Navigation Links
Alere Inc. Schedules Conference Call for 10:00 a.m. ET July 28, 2010 to Discuss Second Quarter 2010 Results
Date:7/21/2010

WALTHAM, Mass., July 21 /PRNewswire-FirstCall/ -- Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its second quarter 2010 earnings on Wednesday, July 28, 2010. The Company will also host a conference call beginning at 10:00 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing 706-679-1656 (domestic and international), an access code is not required, or via a link on the Alere website at www.alere.com/ic.  It is also available via link at http://event.meetingstream.com/r.htm?e=228683&s=1&k=0E445AC7F725CFFA3E6F855A0C7A7BFD.  An archive of the call will be available from the same link approximate
'/>"/>

SOURCE Alere Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Inverness Medical Innovations Changes Name to Alere
2. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
3. Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
7. Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings
8. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
9. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
10. VirtualScopics Schedules Third Quarter 2009 Earnings Announcement
11. Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... WESTFORD, Mass., July 28, 2015   Cynosure, ... manufactures and markets medical devices for aesthetic procedures ... results for the three months ended June 30, ... another quarter of double-digit growth, as revenues increased ... said Cynosure Chief Executive Officer Michael Davin. "While ...
(Date:7/28/2015)... , July 28, 2015  Today, Sekisui Diagnostics announces ... affordable and efficient instrument, with a broad menu of ... benefits to the physicians, office or hospital laboratory. ... to 580 tests/hour with ISE, 72 patient sample on-board ... 36 onboard assays (+3 ISE) to meet the testing ...
(Date:7/28/2015)... Baebies, Inc. today announced the completion of ... oversubscribed round of financing included key investors Rex Health ... Capital, Triad, LLC, the Duke Angel Network and a ... Advanced Liquid Logic,s (ALL) former investors including Charleston Angel ... "Rex is pleased to support this promising young ...
Breaking Medicine Technology:Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13Sekisui Diagnostics Announces Launch of SK500 Clinical Chemistry System for US Laboratories 2Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2
... Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a ... the second quarter of 2011. Soligenix’s ... $406,000 as compared to $445,000 for the second quarter ... a result of completion in April 2011 of the ...
... NeurogesX, Inc. (NASDAQ: NGSX ), a biopharmaceutical ... therapies, announced today that Stephen Ghiglieri, Executive Vice President, ... to present at the 2011 Wedbush Life Sciences: Management ... Le Parker Meridien in New York, NY. Mr. Ghiglieri ...
Cached Medicine Technology:Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments 2Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments 3Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments 4Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments 5NeurogesX to Present at 2011 Wedbush Life Sciences Conference 2NeurogesX to Present at 2011 Wedbush Life Sciences Conference 3
(Date:7/28/2015)... La Mirada, CA (PRWEB) , ... July 28, 2015 , ... ... XC, a collagen-filling injectable that returns skin to a smooth state, and reduces the ... XC is the “first and only FDA-approved injectable gel to instantly add volume to ...
(Date:7/28/2015)... , ... July 28, 2015 , ... According to ... to stop the cycle of addiction in lab mice. The study involving isradipine has ... the new prospect of helping their clients overcome drug and alcohol addictions. The study ...
(Date:7/28/2015)... TX (PRWEB) , ... July 28, 2015 , ... BMI ... is now offering the duodenal switch weight loss surgery procedure. Committed to ... and bariatric surgery procedures, BMI of Texas is one of the first ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... On July ... officials refused to schedule the hearing of proposed bills and laws revolving the implementation ... new infections to date. Some vigilante ministers are continuing to hand out clean needles ...
(Date:7/28/2015)... , ... July 28, 2015 , ... According to ... Orlando is taking the lead among heroin toxicity cases. According to recent statistic Orlando ... Orlando has become known as a hub of heroin, and law enforcement officials are ...
Breaking Medicine News(10 mins):Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:Blood Pressure Medication May be the Key to Treating Addiction 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 3Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3
... desmoteplase,s poor showing, researchers say , , THURSDAY, Dec. 18 (HealthDay ... of the vampire bat has failed to reduce stroke damage ... called desmoteplase, remains alive, experts say, because the study may ... "The sample size was underpowered to detect any benefit," said ...
... and stiff joints affect many Australians, from the elderly to the ... is offering patients an all natural arthritis treatment called Mobicosa to ... naturally. , ... Melbourne, VIC (PRWEB) December 18, 2008 ...
... www.citepatents.com , to help bloggers, journalists and others easily reference patent ... to websites with a single mouse click. , ... ... to an impartial, peer-reviewed nature, patents are an important, frequently cited ...
... their drugs don,t increase chances of cardiac trouble , , ... and Drug Administration is now asking all companies looking ... undertake studies that determine whether they cause cardiovascular problems. ... the heels of reports that two commonly prescribed blood ...
... Rebiana - Market Leader in New Sweetness Category , ... Minn., Dec. 17 Today, Cargill received official notification ... the agency has no objection to the conclusion of an ... the identity in Truvia(TM) rebiana, is generally recognized as safe ...
... president & CEO , , WASHINGTON, ... President and CEO of the American Association of Homes and Services ... believes there should be two types of nursing homes: the excellent ... , , The five-star rating ...
Cached Medicine News:Health News:Bat Saliva-Based Stroke Drug Disappoints in Trial 2Health News:Bat Saliva-Based Stroke Drug Disappoints in Trial 3Health News:Patients Benefit From Mobicosa, A Unique, Natural Arthritis Treatment Available At Your Chemist Shop 2Health News: FreePatentsOnline Launches the CitePatents Program : Making it Easy for Bloggers and Journalists to Reference Patents, and Add Patent Search to Websites 2Health News:FDA Wants New Diabetes Drugs Tested for Heart Risks 2Health News:Cargill Receives Official Notification From FDA Supporting the Safety of Truvia(TM) Rebiana 2Health News:Cargill Receives Official Notification From FDA Supporting the Safety of Truvia(TM) Rebiana 3Health News:Cargill Receives Official Notification From FDA Supporting the Safety of Truvia(TM) Rebiana 4Health News:AAHSA Statement on CMS Five-Star Rating System for Nursing Homes 2
The Medtronic CardioRhythm Marinr Catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing a...
... designed for use with our CARTO EP ... catheter houses a Biosense Webster sensor at ... time, exact location points from within the ... The NAVI-STAR electro-anatomical navigation catheter is used ...
... Tricuspid Mapping. Biosense Webster offers a complete ... in the atrium. The HALO XP 20-pole ... and mapping around the tricuspid annulus. The ... distal tip (on P15-FS/0 permit pacing in ...
... Webster is the source for a complete ... left-sided mapping - all with the quality, ... expect from the leader in catheter technology. ... specifically designed and constructed to help minimize ...
Medicine Products: